BPI 2026 has ended. This guide stays up as the record of who was there. Next: BPI 2027, Sep 20–23, 2027 in Boston

AI

Astellas Institute for Regenerative Medicine at BPI 2026

Sep 22–25, 2026 Boston, MA ~3k attendees Website

Astellas Institute for Regenerative Medicine takes part in 2 sessions at BPI 2026 in Boston. Its sessions look at cell and gene therapy strategy, from large pharma investment priorities to phase-appropriate manufacturing designed with the end in mind.

OrganizationBPI 2026 Attendance
AI
Astellas Institute for Regenerative Medicine
Large pharma
Astellas subsidiary researching and developing pluripotent stem cell-derived cell therapies.
Keynote
Wed Sep 23
2:00pm–2:40pm
Keynote Panel Discussion- Big Pharma’s Cell and Gene Therapies Wish List: Investment Priorities and Emerging Opportunities
Cell & Gene Keynote Plenary · with Kite Pharma, Dark Horse Consulting
Talk
Thu Sep 24
4:30pm–5:30pm
Panel Discussion: Starting with the End in Mind: Designing Smart and Phase Appropriate Manufacturing for Successful Cell and Gene Therapy Development
Development of Emerging Cell & Gene Therapies · with Mill Creek Consulting, Ultragenyx, Genetix Biotherapeutics

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Astellas Institute for Regenerative Medicine

Tell us what you sell and we’ll find the people at Astellas Institute for Regenerative Medicine most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the BioProcess International Conference & Exhibition or its organizers. Submit a correction